Pharmaceutical firm Gilead Sciences has just put up a cool $11.9 billion to acquire Kite Pharma, which has developed a genetic engineering approach for treating cancers.
{iframe}https://www.technologyreview.com/the-download/608753/a-12-billion-takeover-says-that-gene-therapy-cancer-cures-are-big-business/?utm_source=MIT+Technology+Review&utm_campaign=f70fc2acb6-Weekend_Reads&utm_medium=email&utm_term=0_997ed6f472-f70fc2acb6-153904269&mc_cid=f70fc2acb6&mc_eid=4d778a166c{/iframe}